A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 4,616 shares of BIIB stock, worth $687,876. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,616
Previous 4,634 0.39%
Holding current value
$687,876
Previous $1.07 Million 16.76%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $3,403 - $4,262
-18 Reduced 0.39%
4,616 $894,000
Q2 2024

Aug 15, 2024

BUY
$190.52 - $236.72 $6,858 - $8,521
36 Added 0.78%
4,634 $1.07 Million
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $2,544 - $3,212
12 Added 0.26%
4,598 $991,000
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $3,338 - $4,019
15 Added 0.33%
4,586 $1.19 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $1,519 - $1,715
6 Added 0.13%
4,571 $1.17 Million
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $10,734 - $12,404
39 Added 0.86%
4,565 $1.3 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $3,591 - $4,092
14 Added 0.31%
4,526 $1.26 Million
Q4 2022

Feb 21, 2023

SELL
$252.44 - $306.72 $221,389 - $268,993
-877 Reduced 16.27%
4,512 $1.25 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $90,336 - $124,565
-464 Reduced 7.93%
5,389 $1.44 Million
Q2 2022

Aug 04, 2022

SELL
$187.54 - $223.02 $121,525 - $144,516
-648 Reduced 9.97%
5,853 $1.19 Million
Q1 2022

May 09, 2022

SELL
$193.77 - $244.14 $152,109 - $191,649
-785 Reduced 10.77%
6,501 $1.37 Million
Q4 2021

Feb 03, 2022

SELL
$223.92 - $287.77 $42,768 - $54,964
-191 Reduced 2.55%
7,286 $1.75 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $181,396 - $236,561
641 Added 9.38%
7,477 $2.12 Million
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $17,871 - $28,614
-69 Reduced 1.0%
6,836 $2.37 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $373,900 - $438,045
-1,539 Reduced 18.23%
6,905 $1.93 Million
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $123,091 - $185,283
-521 Reduced 5.81%
8,444 $2.07 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $114,327 - $151,407
-442 Reduced 4.7%
8,965 $2.4 Million
Q1 2020

May 08, 2020

BUY
$268.85 - $341.04 $644,702 - $817,813
2,398 Added 34.21%
9,407 $2.98 Million
Q4 2019

Feb 07, 2020

SELL
$220.06 - $304.07 $3,300 - $4,561
-15 Reduced 0.21%
7,009 $2.08 Million
Q3 2019

Nov 06, 2019

SELL
$217.44 - $243.88 $71,972 - $80,724
-331 Reduced 4.5%
7,024 $1.64 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $4.94 Million - $5.45 Million
-22,536 Reduced 75.39%
7,355 $1.72 Million
Q1 2019

May 10, 2019

SELL
$216.71 - $338.96 $102,287 - $159,989
-472 Reduced 1.55%
29,891 $7.07 Million
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $1.36 Million - $1.72 Million
-4,888 Reduced 13.87%
30,363 $9.14 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $1.51 Million - $1.98 Million
-5,157 Reduced 12.76%
35,251 $12.5 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $489,030 - $582,822
1,899 Added 4.93%
40,408 $11.7 Million
Q1 2018

May 14, 2018

SELL
$260.13 - $367.91 $2.41 Million - $3.4 Million
-9,248 Reduced 19.36%
38,509 $10.5 Million
Q4 2017

Feb 13, 2018

BUY
$307.64 - $344.58 $108,596 - $121,636
353 Added 0.74%
47,757 $15.2 Million
Q3 2017

Nov 13, 2017

SELL
$281.15 - $329.69 $454,057 - $532,449
-1,615 Reduced 3.29%
47,404 $14.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
40,663 Added 486.63%
49,019 $13.3 Million
Q2 2017

Aug 09, 2017

BUY
N/A
8,356
8,356 $2.02 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.